Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial
Background: Despite multiple therapy regimens, the decline in the Helicobacter pylori eradication rate poses a significant challenge to the medical community. Adding Lactobacillus reuteri probiotic as an adjunct treatment has shown some promising results. This study aims to investigate the efficacy...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Wiley
2023
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2756/ https://doi.org/10.1111/hel.13017 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|